› Forums › General Melanoma Community › BRAF Mutation Question
- This topic has 17 replies, 5 voices, and was last updated 6 years, 8 months ago by Jlwood.
- Post
-
- May 31, 2011 at 7:04 pm
I am one of the "lucky" ones with the BRAF mutation or so says my ONC. Anyway my question for some of the more well studied in this group, if you have a gene mutation does that mean it effects you no matter you status (ie NED). Specifically, is that Gene mutated within your body not just a Melanoma Tumor? What got me wondering was when my Onc suggested I have my regular cancer screenings Breast, Colon, etc more frequently. Then I started reading the BRAF shows in Colon, non small lung, etc. What I know about genes I can fill on about two l
I am one of the "lucky" ones with the BRAF mutation or so says my ONC. Anyway my question for some of the more well studied in this group, if you have a gene mutation does that mean it effects you no matter you status (ie NED). Specifically, is that Gene mutated within your body not just a Melanoma Tumor? What got me wondering was when my Onc suggested I have my regular cancer screenings Breast, Colon, etc more frequently. Then I started reading the BRAF shows in Colon, non small lung, etc. What I know about genes I can fill on about two lines.
Thanks,
Mary
- Replies
-
-
- May 31, 2011 at 8:10 pm
Very good question.
Yes, you are correct, the BRAF gene is mutated within the body, and can even be inherited as well. Or, the mutation can also appear as we age and cause cancer as what is called a acquired mutations or oncogene, which is a gene that has the potential to cause cancer. In tumor cells, they are often mutated or expressed at high levels.
Many abnormal cells normally undergo a programmed form of death (apoptosis). Activated oncogenes can cause those cells to survive and proliferate instead. Most oncogenes require an additional step, such as mutations in another gene, or environmental factors, such as viral infection, to cause cancer. Since the 1970s, dozens of oncogenes have been identified in human cancer. Many cancer drugs such as PLX4032 (also known as vemurafenib, RG7204 or RO5185426) target those DNA sequences.
Michael
-
- May 31, 2011 at 11:13 pm
Michael, so am I interpreting my Mel Onc statements correctly, that he wants my other screenings more frequently than would otherwise be indicated for my age, etc. because of the BRAF mutation. That's something I hadn't considered. Yeah, I get to support more docs!
Thanks Micheal.
-
- May 31, 2011 at 11:13 pm
Michael, so am I interpreting my Mel Onc statements correctly, that he wants my other screenings more frequently than would otherwise be indicated for my age, etc. because of the BRAF mutation. That's something I hadn't considered. Yeah, I get to support more docs!
Thanks Micheal.
-
- May 31, 2011 at 8:10 pm
Very good question.
Yes, you are correct, the BRAF gene is mutated within the body, and can even be inherited as well. Or, the mutation can also appear as we age and cause cancer as what is called a acquired mutations or oncogene, which is a gene that has the potential to cause cancer. In tumor cells, they are often mutated or expressed at high levels.
Many abnormal cells normally undergo a programmed form of death (apoptosis). Activated oncogenes can cause those cells to survive and proliferate instead. Most oncogenes require an additional step, such as mutations in another gene, or environmental factors, such as viral infection, to cause cancer. Since the 1970s, dozens of oncogenes have been identified in human cancer. Many cancer drugs such as PLX4032 (also known as vemurafenib, RG7204 or RO5185426) target those DNA sequences.
Michael
-
- June 1, 2011 at 12:41 am
I have not been Braf tested nor do I know much about it.
But one question: are there more and better medicines for Braf positives than for "regular" melanoma?
Are the survival rates better for Braf positives?
Nicki, Stage 3b, scalp
-
- June 1, 2011 at 1:06 am
Another hard question.
About 60% of melanomas contain a mutation in the B-RAF gene
Depending on which study one reads, the BRAF drugs such as plx-4032 (RG7204) offer a good response rate, but the problem is that the melanoma eventually finds a way around the drug through another pathway or pathways and begins to grow again, thus the response is not long lasting.
In one study: 32 patients with melanoma, all with the BRAF V600E mutation were
given 960 mg of PLX4032 twice daily; 26 had a response. The median survival without the melanoma progressing was estimated to be more than 7 months and the estimated median overall survival had not been reached by the time of the study report.Michael
-
- June 1, 2011 at 1:06 am
Another hard question.
About 60% of melanomas contain a mutation in the B-RAF gene
Depending on which study one reads, the BRAF drugs such as plx-4032 (RG7204) offer a good response rate, but the problem is that the melanoma eventually finds a way around the drug through another pathway or pathways and begins to grow again, thus the response is not long lasting.
In one study: 32 patients with melanoma, all with the BRAF V600E mutation were
given 960 mg of PLX4032 twice daily; 26 had a response. The median survival without the melanoma progressing was estimated to be more than 7 months and the estimated median overall survival had not been reached by the time of the study report.Michael
-
- You must be logged in to reply to this topic.